Tran Dien Minh, Tran Vinh Quang, Nguyen Mai Tuan, Mai Duyen Dinh, Doan Anh Vuong, Hoang Son Thanh, Kotani Yasuhiro, Nguyen Truong Ly-Thinh
Department of Surgical ICU, Vietnam National Children's Hospital, Hanoi, Vietnam.
Department of Cardiovascular Surgery, Heart Center, Vietnam National Children's Hospital, Hanoi, Vietnam.
Innovations (Phila). 2024 Sep-Oct;19(5):520-525. doi: 10.1177/15569845241273650. Epub 2024 Aug 26.
To evaluate the safety and efficacy of surgical repair for patients diagnosed with simple congenital heart defects (CHD) using the minimally invasive right vertical infra-axillary minithoracotomy (RVIAT) approach.
We retrospectively reviewed the clinical data of consecutive patients who underwent minimally invasive RVIAT for repair of CHD between August 2019 and August 2022. There were 382 patients who underwent 8 primary procedures and were included in this study.
The median age of the patients was 16.2 (interquartile range [IQR], 7.2 to 41.9) months, and the median weight of the patients was 8.8 (IQR, 6.5 to 14) kg. The preoperative diagnoses were as follows: ventricular septal defect, atrial septal defect, partial anomalous pulmonary venous return, partial atrioventricular septal defect, cor triatriatum, complete atrioventricular septal defect, and myxoma. The mean aortic cross-clamp time, bypass time, and operation time were 45.4 ± 19.3 min, 65.6 ± 23.1 min, and 154.5 ± 29.7 min, respectively. There was no in-hospital mortality or conversion to median sternotomy. Two patients (0.5%) required early reoperation; 1 due to postoperative bleeding and 1 for permanent pacemaker implantation. Other complications included trivial residual shunts (23 of 382, 6%), pleural effusion (3 of 382, 0.8%), pneumothorax (0.8%), and wound infection (4 of 382, 1%). There were 2 late noncardiac deaths. Late reoperation was performed on 1 patient with progressive aortic valve regurgitation who required aortic valvuloplasty.
RVIAT is a minimally invasive approach that can be safely performed on patients with simple CHDs. RVIAT may be a good alternative approach for median sternotomy and cardiac intervention.
评估采用微创右腋下垂直小切口(RVIAT)入路对诊断为单纯先天性心脏病(CHD)的患者进行手术修复的安全性和有效性。
我们回顾性分析了2019年8月至2022年8月期间连续接受微创RVIAT治疗CHD的患者的临床资料。共有382例患者接受了8种主要手术,并纳入本研究。
患者的中位年龄为16.2(四分位间距[IQR],7.2至41.9)个月,中位体重为8.8(IQR,6.5至14)kg。术前诊断如下:室间隔缺损、房间隔缺损、部分性肺静脉异位引流、部分性房室间隔缺损、三房心、完全性房室间隔缺损和黏液瘤。平均主动脉阻断时间、体外循环时间和手术时间分别为45.4±19.3分钟、65.6±23.1分钟和154.5±29.7分钟。无院内死亡或转为正中开胸手术。两名患者(0.5%)需要早期再次手术;1例因术后出血,1例因植入永久性起搏器。其他并发症包括微量残余分流(382例中的23例,6%)、胸腔积液(382例中的3例,0.8%)、气胸(0.8%)和伤口感染(382例中的4例,1%)。有2例晚期非心脏死亡。1例进行性主动脉瓣反流患者需要进行主动脉瓣成形术,接受了晚期再次手术。
RVIAT是一种微创方法,可安全地应用于单纯CHD患者。RVIAT可能是正中开胸手术和心脏介入治疗的一种良好替代方法。